Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

CareView Communications (CRVW) Research & Development (2016 - 2026)

CareView Communications' Research & Development history spans 16 years, with the latest figure at $1.3 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 51.68% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.5 million, a 40.33% increase, with the full-year FY2025 number at $3.0 million, down 6.73% from a year prior.
  • Research & Development hit $1.3 million in Q4 2025 for CareView Communications, up from $610113.0 in the prior quarter.
  • Over the last five years, Research & Development for CRVW hit a ceiling of $1.4 million in Q4 2021 and a floor of $298521.0 in Q4 2022.
  • Historically, Research & Development has averaged $714019.4 across 5 years, with a median of $696508.5 in 2021.
  • Biggest five-year swings in Research & Development: crashed 79.03% in 2022 and later soared 265.26% in 2023.
  • Tracing CRVW's Research & Development over 5 years: stood at $1.4 million in 2021, then plummeted by 79.03% to $298521.0 in 2022, then soared by 265.26% to $1.1 million in 2023, then decreased by 22.9% to $840681.0 in 2024, then soared by 51.68% to $1.3 million in 2025.
  • Business Quant data shows Research & Development for CRVW at $1.3 million in Q4 2025, $610113.0 in Q3 2025, and $748352.0 in Q2 2025.